Total Lung Lavage using THRIVE for Pre-oxygenation and Oxygen Insufflation During Intubation: Our Initial Experience of Two Cases

Vol 6 | Issue 3 | September-December 2020 | Page 11-13 | Vaibhavi V. Baxi, Mansimran K. Kulaar, Aarti Kulkarni


Author: Vaibhavi V. Baxi [1], Mansimran K. Kulaar [1], Aarti Kulkarni [1]

[1] Department of Anaesthesia, Lilavati Hospital And Research Centre, Mumbai, Maharashtra, India

Address of Correspondence
Dr. Vaibhavi V. Baxi,
Consultant Anesthetist, Lilavati Hospital and Research Centre, Bandra west, Mumbai, Maharshtra, India.
E-mail: drvaibhavi13@gmail.com


Total Lung Lavage using THRIVE for Pre-oxygenation and Oxygen Insufflation During Intubation: Our Initial Experience of Two Cases


Abstract

Introduction: Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by deposition of lipoproteinaceous material in the alveoli secondary to abnormal processing of surfactant by macrophages. Total-lung lavage (TLL); a gold standard management for this disease entails washing out the proteinaceous material from the alveoli and re-establish effective oxygenation and ventilation. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE), utilizes apnoeic oxygenation to extend the apnoeic window and delay rapid de-saturation common in these cases; thus allowing for safer intubation. We would like to share our experience of two cases of TLL for PAP in which we used THRIVE for pre-oxygenation and apnoeic oxygenation during intubation. To our knowledge this is the first case report demonstrating the use of THRIVE in a case of TLL in literature.
Case presentation: We had two patients posted for TLL who were suffering from PAP; both had presented with breathlessness of increasing severity over the last few months. Both patients were young (35 & 40 yrs old) and had no other co-morbidities. Their baseline oxygen saturations (SpO2) and partial pressure of oxygen in blood (pO2) on air were on the lower side. Hence the decision was taken to pre-oxygenate them using THRIVE and to also use THRIVE during intubation to improve their tolerance to apnoea during intubation.
Conclusion: When used for pre-oxygenation and oxygen insufflation during intubation THRIVE prolongs the tolerable apnoea time and delays de-saturation during intubation.
Keywords: Pulmonary alveolar proteinosis (PAP), Total Lung Lavage (TLL), Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE).


References

1. Hadda V, Tiwari P, Madan K, Mohan K, Gupta N, Bharati SJ et al. Pulmonary alveolar proteinosis: Experience from a tertiary care center and systematic review of Indian literature. Lung India. 2016;33(6):626–634.
2. Awab A, Khan MS, Youness HA. Whole lung lavage – technical challenges and management of complications. J Thorac Dis. 2017;9(6):1697-1706.
3. Borie R, Danel C, Debray MP, Taille C, Dombret MC, Aubier M, Epaud R, Crestani B. Pulmonary alveolar proteinosis. European Respiratory Review. 2011 Jun 1;20(120):98-107.
4. Holbert JM, Costello P, Li W, Hoffman RM, Rogers RM. CT features of pulmonary alveolar proteinosis. AJR Am J Roentgenmaol. 2001;176(5):1287–94.
5. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: Clinical aspects and current concepts on pathogenesis. Thorax. 2000;55:67–77.
6. Rogers RM, Levin DC, Gray BA, Moseley LW., Jr Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis. 1978;118(2):255–64.
7. Du Bois RM, McAllister WA, Branthwaite MA. Alveolar proteinosis: diagnosis and treatment over a 10-year period. Thorax. 1983;38:360–3.
8. Kariman K, Kylstra JA, Spock A. Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years. Lung. 1984;162(4):223–31.
9. Bartlett RG Jr, Brubach HF, Specht H. Demonstration of aventilatory mass flow during ventilation and apnea in man. Journal of Applied Physiolology 1959; 14: 97–101.
10. Patel A, Nouraei SA. Transnasal Humidified Rapid-InsufflationVentilatory Exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia. 2015;70(3):323-329.
11. Mir F, Patel A, Iqbal R, Cecconi M, Nouraei SA. A randomised controlled trial comparing THRIVE preoxygenation with facemask preoxygenation in patients undergoing rapid sequence induction of anaesthesia. Anaesthesia. 2017;72(4):439-443.
12. Lodenius A, Piehl J, Ostlund A, Ullman J, Jonsson Fagerlund M. THRIVE vs facemask breathing preoxygenation for rapid sequence induction in adults: a prospective randomised non blinded clinical trial. Anaesthesia. 2018;73(5):564-571.
13. Ansari BM, Hogan MP, Collier TJ, et al. A randomized controlled trial of high flow nasal oxygen (optiflow)as part of an Enhanced recovery after surgery (ERAS) after lung resection surgery. Ann Thorac surg. 2016;101(2):459-464.


How to Cite this Article: Baxi VV, Kulaar MK, Kulkarni A | Total Lung Lavage using THRIVE for Pre-oxygenation and Oxygen Insufflation During Intubation: Our Initial Experience of Two Cases | Journal
of Anaesthesia and Critical Care Case Reports | September-December 2020; 6(3): 11-13.

(Abstract) (Text HTML) (Download PDF)